HLN
Haleon plcNYSE
Healthcare • Drug Manufacturers - Specialty & Generic
Updated 1 day ago
Coverage limited
$9.44-0.63%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- +0.5%
- 3 months
- -3.2%
- 1 year
- +4.9%
- 52-week range
- $8.70$11.27
- Dividend, last 12 mo
- $0.198 · 2.10% yield
- Last ex-date
- Aug 14, 2026 · $0.0647
- Dividend growth
- 2+ years in a row
- Short interest
- 24.8M sharessettled Sep 30, 2026 · +13.9% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if HLN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
73 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
646 filers reported a long position in HLN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| DODGE & COX | $1.4B | 149.9M | +2.3% |
| FMR LLC | $1.1B | 121M | +6.2% |
| Clearbridge Investments, LLC | $301.8M | 32.3M | +2% |
| MORGAN STANLEY | $181.6M | 19.5M | +1.5% |
| HARRIS ASSOCIATES L P | $157.1M | 16.8M | +12% |
| HARDING LOEVNER LP | $147.8M | 15.4M | -1.9% |
| Nuveen, LLC | $143.1M | 15.3M | +76.3% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $132.3M | 14.2M | -3.4% |
| BANK OF AMERICA CORP /DE/ | $101.2M | 10.9M | -0.8% |
| JPMORGAN CHASE & CO | $101M | 10.8M | +30.7% |
Get the Full Analysis for HLN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.